Femasys Inc. (FEMY) vs Harvard Bioscience, Inc. (HBIO)
- Femasys Inc. FEMY 1.65 −5.17%
- Harvard Bioscience, Inc. HBIO 8.09 −2.65%
Femasys Inc. and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $37.8M against $14.5M — 2.6× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against −1.06%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −534.3%) and the higher return on invested capital (−0.41% vs −176.9%). Across the 18 metrics below, Harvard Bioscience, Inc. leads on 10 and Femasys Inc. on 8.
Valuation
Profitability
| Metric | FEMY | HBIO | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.95% | 58.16% | 54.29% |
| Operating margin | (763.90%) | (0.28%) | 1.07% |
| Net margin | (534.27%) | (11.86%) | (1.61%) |
| Free cash flow margin | (786.02%) | (2.09%) | 1.08% |
| Return on equity | (443.65%) | (89.95%) | (1.32%) |
| Return on assets | (94.25%) | (13.32%) | 0.00% |
| Return on invested capital | (176.91%) | (0.41%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack